Better Big Pharma Dividend Stock: Pfizer Or Teva? | Seeking Alpha
Manufacturing alerts and issues at Teva, Pfizer, and more
Pfizer, Teva and Actavis Vie to Buy Ratiopharm - The New York Times
Teva Pharmaceuticals, 20 others accused of illegal drug price hikes
Recon: FDA clears Pfizer booster for 12- to 15-year-olds; Teva found liable in New York opioid trial | RAPS
Pfizer's Kindler KO'd by Teva's Yanai
Pfizer's legendary Viagra finally set to face cheaper competition in U.S. | Fierce Pharma
Teva to enter Lipitor generic market - Pharmaceutical Technology
Pfizer, Teva running short on antibiotic azithromycin amid COVID-19 therapy hunt | Fierce Pharma
Pfizer links with Synthon on generic Copaxone - PMLiVE
Pfizer in $2.15 Billion Settlement From Teva and Sun for Patent Infringement
Manufacturing alerts and issues at Teva, Pfizer, and more
Pfizer, Teva reach deal to allow generic Viagra-World News , Firstpost
Pfizer, AstraZeneca, Merck, and Teva win tender for new Israeli Innovation Lab | Ctech
Pfizer and Teva Enter into Settlement Agreement in Patent Dispute Over Xeljanz - IP News Shots
Pfizer sues Teva over arthritis treatment
Teva Takes Pfizer and BMS to Court Over Blood Thinner UK Patents - IP News Shots
Pfizer scrambles to fill void after Teva stops making chemo drug often given to children | Fierce Pharma
Pfizer, GSK and Teva lead 2022's round of January drug price hikes: GoodRx | Fierce Pharma
Pfizer reaches $2 billion Protonix settlement with Teva and Sun Pharma - The Economic Times
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Pfizer and Regeneron led pharma's sales growth in Q4 while Teva, Biogen and Gilead lagged | Fierce Pharma
